Transplant Diagnostics Market Analysis with Technological Advancements and Future Growth Trends to 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (hospitals & Transplant services, research & academic institutes, and independent reference laboratories.)- Market Outlook And Industry Analysis 2031"

The Global Transplant Diagnostics Market is estimated to reach over USD 8.26 billion by 2031, exhibiting a CAGR of 7.7% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1760

The growth of the global transplant diagnostics market is driven by several key factors, including the rising adoption of stem cell-based, soft tissue, and solid organ transplantation, the increasing prevalence of chronic diseases, the expansion of laboratory automation in diagnostic procedures through robotic assistance, and technological advancements in human leukocyte antigen (HLA) typing.

Additional factors contributing to market expansion include increased public and private sector investments in the development of innovative HLA testing products, the rapid growth of HLA diagnostic applications, and improvements in healthcare infrastructure, particularly in developing economies. The declining average cost of gene sequencing and the growing installed base of next-generation sequencing (NGS) and polymerase chain reaction (PCR) instruments are also expected to drive market growth.

According to industry leaders, the market is being propelled by the rising number of organ transplant procedures, technological advancements, increasing incidence of chronic diseases, and growing research and development (R&D) activities. However, market growth is limited by the shortage of suitable organs for transplant procedures, challenges related to HLA sequencing, and a general lack of awareness about transplant diagnostics. Currently, the consumables segment accounts for the largest share of market revenue. Small and medium-sized enterprises (SMEs) report that the rising demand for organ transplants is contributing to increased costs associated with transplant diagnostics.

Moreover, major manufacturers and distributors of transplant diagnostics are focusing on expanding their presence in emerging markets due to their significant growth potential. The increasing prevalence of chronic diseases in these regions is a key factor driving this strategic shift.

List of Prominent Players in the Transplant Diagnostics Market:
• Abbott Laboratories, Inc.
• Adaptive Biotechnologies
• Affymetrix, Inc.
• altona Diagnostics GmbH
• Arquer Diagnostics Ltd
• BAG Diagnostics GmbH
• Becton, Dickinson and Company,
• Biofortuna Limited
• BioMerieux SA,
• Bio-rad Laboratories, Inc.
• Biotype GmbH
• Bruker,
• CareDx Inc.
• CLONIT srl
• Diagnóstica Longwood SL
• DiaSorin S.p.A.
• ELITechGroup
• EUROFINS VIRACOR
• F. Hoffmann La-Roche AG.
• Hologic, Inc.
• Horiba Ltd
• Illumina, Inc.
• Immucor Transplant Diagnostics, Inc.
• Laboratory Corporation of America Holdings.
• Linkage Biosciences
• Luminex Corporation
• Merck KGaA
• NanoString
• Olerup SSP AB
• Omixon Ltd.
• PathoNostics
• Preservation Solutions, Inc.
• Qiagen N.V.
• Randox Laboratories Ltd.
• Stryker
• Takara Bio Inc.
• Thermo Fisher Scientific,
• TransMedics
• Transonic
• Zimmer Biomet

Market Dynamics:
Drivers-
The transplant diagnostics market is being driven by the increasing incidence of organ failure resulting from acute diseases, which is subsequently raising the demand for transplant procedures. The success of an organ transplant is highly dependent on the recipient's ability to accept the donor organ. To determine the likelihood of a successful transplant, diagnostic tests are conducted to assess organ compatibility and minimize the risk of rejection.

According to the United Network for Organ Sharing (UNOS), a U.S.-based non-profit organization that manages the country's organ transplantation process, organ transplants in the United States reached a record high in 2021. That year, there were 3,817 heart transplants, 24,669 liver transplants, and 9,236 kidney transplants. The increasing demand for diagnostic tests to support these procedures is a key factor driving the expansion of the transplant diagnostics market.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Challenges:
A significant gap between the demand for organ transplants and the availability of donor organs is hindering the growth of the transplant diagnostics market. The need for organ transplants is increasing at a faster rate than the number of available donors. According to the Health Resources and Services Administration, 106,090 individuals were on the organ transplant waiting list in 2021. This growing imbalance between supply and demand is contributing to a severe organ shortage, which in turn limits the demand for transplant diagnostic tests and related technologies, thereby restraining market growth.

Regional Trends:
The global transplant diagnostics market is segmented into six key regions: North America, Latin America, the Middle East and Africa, Europe, Asia Pacific, and the Rest of the World. North America holds a dominant position in the global market due to the region's well-established organ transplantation infrastructure, a growing stem cell donor base, increased private and public investments in developing HLA typing technology, and declining average costs of gene sequencing. In the Asia Pacific region, China and India are expected to experience the highest growth rates in the transplant diagnostics market over the next five years, driven by increasing healthcare infrastructure and rising demand for organ transplants.

Recent Developments:
• In March 2022, Immucor, Inc., a business specialising in transfusion and transplantation diagnostics, introduced two new products to its transplant diagnostics line, proving its dedication to recent developments in the histocompatibility industry.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2444

Segmentation of Transplant Diagnostics Market-
By Technology-
• Molecular assay technologies
o PCR based molecular assays
o Real-time PCR
o Sequence-specific primer-PCR
o Sequence-specific Oligonucleotide-PCR
o Other PCR-based molecular assays
• Sequencing based molecular assays
o Sanger sequencing
o Next generation sequencing
o Others
• Non molecular assays technologies
By Product & Service-
• Reagents & Consumables
• Instruments
• Software & Services
By Application-
• Diagnostic Application
o Pre-Transplantation
 Infectious Disease Testing
 Histocompatibility Testing
 Blood Profiling
o Post-Transplantation Diagnostics
• Research Applications
By Transplant Type-
• Solid organ transplantation
o Kidney
o Liver
o Heart
o Lung
o Pancrease
o Others
• Stem Cell Transplantation
• Soft Tissue Transplantation
• Bone Marrow Transplantation
By End-User-
• Hospitals & Transplant Centers
• Research & Academic Institutes
• Independent Research Laboratories
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.